SE0303400D0 - Sårvårdsprodukt innehållande ett ämne som hämmar tillväxt av bakterier i sår - Google Patents

Sårvårdsprodukt innehållande ett ämne som hämmar tillväxt av bakterier i sår

Info

Publication number
SE0303400D0
SE0303400D0 SE0303400A SE0303400A SE0303400D0 SE 0303400 D0 SE0303400 D0 SE 0303400D0 SE 0303400 A SE0303400 A SE 0303400A SE 0303400 A SE0303400 A SE 0303400A SE 0303400 D0 SE0303400 D0 SE 0303400D0
Authority
SE
Sweden
Prior art keywords
substance
wound care
care product
wounds
inhibits
Prior art date
Application number
SE0303400A
Other languages
English (en)
Other versions
SE0303400L (sv
SE526313C2 (sv
Inventor
Aasa Melhus
Stefan Areskoug
Original Assignee
Moelnlycke Health Care Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moelnlycke Health Care Ab filed Critical Moelnlycke Health Care Ab
Priority to SE0303400A priority Critical patent/SE526313C2/sv
Publication of SE0303400D0 publication Critical patent/SE0303400D0/sv
Priority to RU2006121491/15A priority patent/RU2354407C2/ru
Priority to BRPI0417443-7A priority patent/BRPI0417443A/pt
Priority to MXPA06006692A priority patent/MXPA06006692A/es
Priority to AU2004298970A priority patent/AU2004298970A1/en
Priority to JP2006545288A priority patent/JP2007514743A/ja
Priority to EP10183952A priority patent/EP2389957A1/en
Priority to CA002548588A priority patent/CA2548588A1/en
Priority to US10/583,130 priority patent/US20070141129A1/en
Priority to PCT/SE2004/001890 priority patent/WO2005058381A1/en
Priority to CNB2004800377746A priority patent/CN100457196C/zh
Priority to EP04809064A priority patent/EP1694371A1/en
Publication of SE0303400L publication Critical patent/SE0303400L/sv
Publication of SE526313C2 publication Critical patent/SE526313C2/sv
Priority to ZA200604771A priority patent/ZA200604771B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/63—Crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0303400A 2003-12-17 2003-12-17 Sårvårdsprodukt innehållande ett ämne som hämmar tillväxt av bakterier i sår SE526313C2 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE0303400A SE526313C2 (sv) 2003-12-17 2003-12-17 Sårvårdsprodukt innehållande ett ämne som hämmar tillväxt av bakterier i sår
EP04809064A EP1694371A1 (en) 2003-12-17 2004-12-16 Wound care product comprising a substance which inhibits the growth of bacteria in wounds
EP10183952A EP2389957A1 (en) 2003-12-17 2004-12-16 Wound care product comprising a substance which inhibits the growth of bacteria in wounds
US10/583,130 US20070141129A1 (en) 2003-12-17 2004-12-16 Wound care product comprising a substance which inhibits the growth of bacteria in wounds
MXPA06006692A MXPA06006692A (es) 2003-12-17 2004-12-16 Producto para el cuidado de las heridas que contiene una sustancia que inhibe el crecimiento de bacterias en las heridas.
AU2004298970A AU2004298970A1 (en) 2003-12-17 2004-12-16 Wound care product comprising a substance which inhibits the growth of bacteria in wounds
JP2006545288A JP2007514743A (ja) 2003-12-17 2004-12-16 創傷における細菌の増殖を阻害する物質を含む創傷ケア製品
RU2006121491/15A RU2354407C2 (ru) 2003-12-17 2004-12-16 Защитное изделие для ран, включающее в себя вещество, которое препятствует росту бактерий в ранах
CA002548588A CA2548588A1 (en) 2003-12-17 2004-12-16 Wound care product comprising a substance which inhibits the growth of bacteria in wounds
BRPI0417443-7A BRPI0417443A (pt) 2003-12-17 2004-12-16 produto para cuidado de ferimentos compreendendo uma substáncia que inibe o crescimento de bactérias no ferimento
PCT/SE2004/001890 WO2005058381A1 (en) 2003-12-17 2004-12-16 Wound care product comprising a substance which inhibits the growth of bacteria in wounds
CNB2004800377746A CN100457196C (zh) 2003-12-17 2004-12-16 包含抑制创伤中细菌生长的物质的创伤护理产品、其制备方法及应用
ZA200604771A ZA200604771B (en) 2003-12-17 2006-06-09 Wound care product comprising a substance which inhibits the growth of bacteria in wounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303400A SE526313C2 (sv) 2003-12-17 2003-12-17 Sårvårdsprodukt innehållande ett ämne som hämmar tillväxt av bakterier i sår

Publications (3)

Publication Number Publication Date
SE0303400D0 true SE0303400D0 (sv) 2003-12-17
SE0303400L SE0303400L (sv) 2005-06-18
SE526313C2 SE526313C2 (sv) 2005-08-23

Family

ID=30439716

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303400A SE526313C2 (sv) 2003-12-17 2003-12-17 Sårvårdsprodukt innehållande ett ämne som hämmar tillväxt av bakterier i sår

Country Status (12)

Country Link
US (1) US20070141129A1 (sv)
EP (2) EP1694371A1 (sv)
JP (1) JP2007514743A (sv)
CN (1) CN100457196C (sv)
AU (1) AU2004298970A1 (sv)
BR (1) BRPI0417443A (sv)
CA (1) CA2548588A1 (sv)
MX (1) MXPA06006692A (sv)
RU (1) RU2354407C2 (sv)
SE (1) SE526313C2 (sv)
WO (1) WO2005058381A1 (sv)
ZA (1) ZA200604771B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070048345A1 (en) * 2005-08-31 2007-03-01 Kimberly-Clark Worldwide, Inc. Antimicrobial composition
GB0606661D0 (en) 2006-04-03 2006-05-10 Brightwake Ltd Improvements relating to dressings
JP2008266203A (ja) * 2007-04-19 2008-11-06 Bussan Food Science Kk 活性酸素種消去酵素群の活性を向上させる方法
WO2009121183A1 (en) 2008-04-03 2009-10-08 Kane Biotech Inc. Dispersinbtm, 5-fluorouracil, deoxyribonuclease i and proteinase k-based antibiofilm compositions and uses thereof
WO2011076216A2 (en) 2009-12-22 2011-06-30 Rigshospitalet, Copenhagen University Hospital Wound care products
WO2012143013A1 (en) 2011-04-18 2012-10-26 Rigshospitalet Copenhagen University Hospital Improved wound care product
GB2493960B (en) 2011-08-25 2013-09-18 Brightwake Ltd Non-adherent wound dressing
BR112015021755A2 (pt) 2013-03-07 2017-07-18 Kane Biotech Inc composições antimicrobianas e antibiofilmes e métodos de aplicação das mesmas
US10105342B2 (en) 2015-08-05 2018-10-23 Cmpd Licensng, Llc Compositions and methods for treating an infection
US10617703B2 (en) * 2014-12-10 2020-04-14 Cmpd Licensing, Llc Compositions and methods for treating an infection
CN105568552A (zh) * 2016-01-14 2016-05-11 武汉轻工大学 一种槲皮素包合物电纺丝纳米膜、其制备方法及应用
WO2023199057A1 (en) * 2022-04-13 2023-10-19 Brunel University London Compositions for preventing and treating infection comprising an artificial sweetener

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226753A1 (de) * 1982-07-14 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Wundverband zur aufnahme von wundsekret
SE455466C (sv) * 1986-03-10 1993-06-17 Moelnlycke Ab Foerband foer vaetskande saar
GB2192142B (en) 1986-07-04 1990-11-28 Johnson & Johnson Wound dressing
FR2618337B1 (fr) 1987-07-22 1989-12-15 Dow Corning Sa Pansement chirurgical et procede pour le fabriquer
US5099832A (en) * 1988-09-07 1992-03-31 Smith & Nephew Plc Packaged sterile adhesive dressing
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
DE69523443T2 (de) * 1994-02-18 2002-06-27 Kanebo Ltd Material zur wundbedeckung
ATE272397T1 (de) * 1999-04-22 2004-08-15 Shiseido Co Ltd Selektive antibakterielle zusammensetzungen
JP2000302673A (ja) * 1999-04-22 2000-10-31 Shiseido Co Ltd アトピー性皮膚炎用皮膚外用剤
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
JP4347973B2 (ja) * 1999-12-20 2009-10-21 希能 澤口 口腔用又は外用薬組成物
US6455067B1 (en) * 2000-05-24 2002-09-24 Sang-A Pharmaceutical Co., Ltd. Transdermal patch for nonsteroidal antiinflammatory drug(s)
US6867343B2 (en) * 2000-10-27 2005-03-15 Kimberly-Clark Worldwide, Inc. Odor control absorbent article and method
JP2002302404A (ja) * 2001-04-02 2002-10-18 Shiseido Co Ltd 抗菌防黴助剤

Also Published As

Publication number Publication date
CN1893985A (zh) 2007-01-10
CN100457196C (zh) 2009-02-04
MXPA06006692A (es) 2006-08-31
US20070141129A1 (en) 2007-06-21
AU2004298970A1 (en) 2005-06-30
SE0303400L (sv) 2005-06-18
SE526313C2 (sv) 2005-08-23
RU2006121491A (ru) 2007-12-27
ZA200604771B (en) 2007-03-28
JP2007514743A (ja) 2007-06-07
EP1694371A1 (en) 2006-08-30
WO2005058381A1 (en) 2005-06-30
EP2389957A1 (en) 2011-11-30
CA2548588A1 (en) 2005-06-30
RU2354407C2 (ru) 2009-05-10
BRPI0417443A (pt) 2007-03-06

Similar Documents

Publication Publication Date Title
SE0303400D0 (sv) Sårvårdsprodukt innehållande ett ämne som hämmar tillväxt av bakterier i sår
CY1109422T1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
HK1090843A1 (en) Pharmaceutical compositions for healing wounds
DE60335560D1 (de) Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen
AR017021A1 (es) Acido 2-hidroxiacetico
DE60320007D1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE69811371D1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung
NO20050063L (no) 2-heteroaryl karboksamider
AR006652A1 (es) Forma farmacéutica de dosificación oral para el tratamiento oral de enfermedades óseas.
ATE116848T1 (de) Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris.
ATE537837T1 (de) Verwendung von milchsäurebakterien zur verringerung von zahnfleischbluten und mundentzündung
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
ID26055A (id) Senyawa-senyawa hidroksidifenil eter
DE60123100D1 (de) Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung
HRP20050062B1 (hr) Sterilna vodena suspenzija koja sadržava ciklesonid
NO20033161L (no) Linsepleieprodukt inneholdende dexpantenol
DE50312948D1 (de) Alicyclische ester mit moschusgeruch
ATE522218T1 (de) Dosierungseinheit enthaltend prostaglandin-analog zur behandlung von darmverstopfung
DE60318327D1 (de) Verwendung von resveratrol zur herstellung eines arzneimittels zur behandlung von grippe
DE50213650D1 (de) Einrichtung zur Herstellung von Stapelpaketen
ATE359285T1 (de) Verwendung von scopinester derivaten zur herstellung von arzneimitteln
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen

Legal Events

Date Code Title Description
NUG Patent has lapsed